Debt
Senior Notes
The following table summarizes information related to our senior notes:
| | | | | | | | | | | | | | | | | | | | | | | |
| | Issuance Date | Maturity Date | Interest Rate | Principal |
| | | | | As of December 31, |
| | | | | 2025 | | 2024 |
| | | | | (in millions except interest rates) |
Senior notes due 2025 | | March 27, 2015 | April 1, 2025 | 5.25 | % | $ | — | | | $ | 500.0 | |
Senior notes due 2027 | | July 5, 2017 | July 15, 2027 | 4.75 | % | 550.0 | | | 550.0 | |
Senior notes due 2031 | | June 8, 2021 | June 15, 2031 | 2.70 | % | 750.0 | | | 750.0 | |
| Senior notes due 2032 | | March 11, 2025 | June 1, 2032 | 5.25 | % | 500.0 | | | — | |
| Less: unamortized issuance costs | | | | | (11.8) | | | (7.7) | |
Total senior notes | | | | | 1,788.2 | | | 1,792.3 | |
Less: current portion of senior notes due 2025 | | | | | — | | | (299.8) | |
Total long-term senior notes | | | | | $ | 1,788.2 | | | $ | 1,492.5 | |
On March 11, 2025, the Company issued $500.0 million of 5.25% senior unsecured notes due June 1, 2032 (“2032 Notes”). The 2032 Notes were issued at 99.581% of par value. Interest payments on the 2032 Notes commenced June 1, 2025 and are due semi-annually. The total discount and issuance costs of $6.7 million are presented on the balance sheet as a reduction of the debt obligation and are being amortized to Interest expense over the 7-year term of the notes.
On March 31, 2025, the Company used the net proceeds from the 2032 Notes and cash on hand to fund the repayment of all of its $500.0 million aggregate principal amount of outstanding 5.25% senior unsecured notes (“2025 Notes”), prior to their maturity on April 1, 2025.
The $750.0 million of 2.70% senior unsecured notes due June 15, 2031 were issued at 99.712% of par value. The $550.0 million of 4.75% senior unsecured notes due July 15, 2027 were issued at par. All outstanding senior notes are senior unsecured obligations of the Company. Each of the senior notes issuances is redeemable, in whole or in part, at the Company’s option at times and redemption prices specified in the indentures. Interest is payable on each of the senior notes semi-annually. Cash paid for interest was $78.7 million in 2025 and $72.8 million each in 2024 and 2023.
2023 Credit Facility
On December 6, 2023, the Company entered into a credit agreement for a $200.0 million committed unsecured revolving credit facility (the “2023 Credit Facility”) which takes the place of its prior unsecured revolving credit facility. The 2023 Credit Facility includes a financial covenant requiring that the Company’s leverage ratio not exceed 4.0 to 1.0, which may be increased subject to certain conditions defined in the 2023 Credit Facility Agreement. As of December 31, 2025, there were no borrowings outstanding under the 2023 Credit Facility, and the Company was in compliance with the financial covenants. The 2023 Credit Facility expires on December 6, 2028, at which time any outstanding borrowings are due. Verisign may from time to time request lenders to agree on a discretionary basis to increase the commitment amount by up to an aggregate of $150.0 million.
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.